Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 4
2000 3
2001 1
2002 4
2004 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions.
Crystal RG, Harvey BG, Wisnivesky JP, O'Donoghue KA, Chu KW, Maroni J, Muscat JC, Pippo AL, Wright CE, Kaner RJ, Leopold PL, Kessler PD, Rasmussen HS, Rosengart TK, Hollmann C. Crystal RG, et al. Hum Gene Ther. 2002 Jan 1;13(1):65-100. doi: 10.1089/10430340152712647. Hum Gene Ther. 2002. PMID: 11779413 Clinical Trial.
Exogenous control of cardiac gene therapy: evidence of regulated myocardial transgene expression after adenovirus and adeno-associated virus transfer of expression cassettes containing corticosteroid response element promoters.
Lee LY, Zhou X, Polce DR, El-Sawy T, Patel SR, Thakker GD, Narumi K, Crystal RG, Rosengart TK. Lee LY, et al. J Thorac Cardiovasc Surg. 1999 Jul;118(1):26-4, discussion 34-5. doi: 10.1016/S0022-5223(99)70137-6. J Thorac Cardiovasc Surg. 1999. PMID: 10384181 Free article.
Gene therapy with adenovirus-mediated myocardial transfer of vascular endothelial growth factor 121 improves cardiac performance in a pacing model of congestive heart failure.
Leotta E, Patejunas G, Murphy G, Szokol J, McGregor L, Carbray J, Hamawy A, Winchester D, Hackett N, Crystal R, Rosengart T. Leotta E, et al. J Thorac Cardiovasc Surg. 2002 Jun;123(6):1101-13. doi: 10.1067/mtc.2002.121044. J Thorac Cardiovasc Surg. 2002. PMID: 12063456 Free article.
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.
Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG. Rosengart TK, et al. Circulation. 1999 Aug 3;100(5):468-74. doi: 10.1161/01.cir.100.5.468. Circulation. 1999. PMID: 10430759 Clinical Trial.
Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA.
Rosengart TK, Lee LY, Patel SR, Kligfield PD, Okin PM, Hackett NR, Isom OW, Crystal RG. Rosengart TK, et al. Ann Surg. 1999 Oct;230(4):466-70; discussion 470-2. doi: 10.1097/00000658-199910000-00002. Ann Surg. 1999. PMID: 10522716 Free PMC article. Clinical Trial.
13 results